LEXINGTON, Mass., July 20, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today the ...

T2 Biosystems (NASDAQ:TTOO) confirmed its plans to add detection of fungal pathogen Candida auris to its FDA-cleared and CE marked T2Candida Panel. A rare and often deadly fungal species is spreading ...